Kilpatrick, Eric S.

A1C Variability and the Risk of Microvascular Complications in Type 1 Diabetes

Kilpatrick, E. S., Rigby, A. S., & Atkin, S. L. (2008) · Diabetes Care

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 420

The Obesity Paradox in Type 2 Diabetes Mellitus: Relationship of Body Mass Index to Prognosis: A Cohort Study

Costanzo, P., Cleland, J. G. F., Pellicori, P., Clark, A. L., Hepburn, D., Kilpatrick, E. S., Perrone-Filardi, P., Zhang, J., & Atkin, S. L. (2015) · Annals of Internal Medicine

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 199

The biological variation of testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian syndrome: implications for SHBG as a surrogate marker of insulin resistance.

Jayagopal, V., Kilpatrick, E. S., Jennings, P. E., Hepburn, D. A., & Atkin, S. L. (2003) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersClinical Laboratory Practices and Quality Control

Cited by 137

Effects of empagliflozin on metabolic parameters in polycystic ovary syndrome: A randomized controlled study

Javed, Z., Papageorgiou, M., Deshmukh, H., Rigby, A. S., Qamar, U., Abbas, J., Khan, A. Y., Kilpatrick, E. S., Atkin, S. L., & Sathyapalan, T. (2019) · Clinical Endocrinology

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 121

Establishing pragmatic estimated GFR thresholds to guide metformin prescribing

Shaw, J. S., Wilmot, R. L., & Kilpatrick, E. S. (2007) · Diabetic Medicine

Chronic Kidney Disease and DiabetesDiabetes Treatment and Management

Cited by 90

The effects of treatment with liraglutide on atherothrombotic risk in obese young women with polycystic ovary syndrome and controls

Kahal, H., Aburima, A., Ungvari, T., Rigby, A. S., Coady, A. M., Vince, R. V., Ajjan, R. A., Kilpatrick, E. S., Naseem, K. M., & Atkin, S. L. (2015) · BMC Endocrine Disorders

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 74

The effects of empagliflozin vs metformin on endothelial microparticles in overweight/obese women with polycystic ovary syndrome

Javed, Z., Papageorgiou, M., Madden, L. A., Rigby, A. S., Kilpatrick, E. S., Atkin, S. L., & Sathyapalan, T. (2020) · Endocrine Connections

Ovarian function and disordersExtracellular vesicles in disease

Cited by 24

Metformin maintains the weight loss and metabolic benefits following rimonabant treatment in obese women with polycystic ovary syndrome (PCOS)

Sathyapalan, T., Cho, L. W., Kilpatrick, E. S., Coady, A., & Atkin, S. L. (2009) · Clinical Endocrinology

Ovarian function and disordersPharmacology and Obesity Treatment

Cited by 11